DermResearchCenter of New York, Inc

Stony Brook, New York 11790

We've found

2 trials

at this facility

A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Stony Brook, NY

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Stony Brook, NY

Use our guide to learn which trials are right for you!